Olmesartan

Your body has a system called the renin-angiotensin-aldosterone system (RAAS) that helps regulate blood pressure ^[1]. When blood pressure drops or the body senses reduced blood flow to the kidneys, it produces a powerful hormone called angiotensin II.

Angiotensin II raises blood pressure by constricting blood vessels, stimulating the release of aldosterone (which makes the kidneys retain salt and water), and promoting thirst and salt appetite ^[1]. In hypertension, this system is often overactive.

Olmesartan blocks the AT1 receptor — the specific receptor through which angiotensin II exerts most of its blood pressure-raising effects ^[1]. By blocking this receptor, olmesartan prevents blood vessels from constricting, reduces aldosterone release, and decreases sodium and water retention. The net effect is relaxation of blood vessels and lower blood pressure.

Unlike ACE inhibitors (which also target the RAAS), ARBs like olmesartan do not cause the dry cough that is common with ACE inhibitors, because they do not increase bradykinin levels ^[1].

Week 1: Blood pressure begins to decrease within the first 1-2 weeks of treatment ^[1]. You may feel slightly lightheaded as your body adjusts to lower blood pressure. Most people do not feel any noticeable side effects from olmesartan.

Weeks 2-4: The majority of the blood pressure lowering effect is achieved within 2 weeks of starting treatment or after a dose adjustment ^[1]. Your doctor may check your blood pressure and make dose adjustments during this period.

Months 1-3: Blood pressure stabilizes at its new, lower level. Olmesartan is well-tolerated long-term, with side effect rates similar to placebo in clinical trials ^[1]. Routine monitoring of kidney function and potassium levels may be done.

Long-term: Olmesartan maintains its blood pressure-lowering effect over years of continuous use without developing tolerance ^[1]. Consistent daily use is important — even if you feel fine, hypertension is a silent condition that requires ongoing treatment.

Olmesartan has minimal food interactions ^[1].

Food: May be taken with or without food. Food does not affect the bioavailability of olmesartan ^[1].

Salt (sodium): A high-sodium diet can partially counteract the blood pressure-lowering effect of olmesartan. Your doctor may recommend limiting sodium intake to improve blood pressure control.

Potassium-rich foods: Olmesartan can increase potassium levels. While you do not need to avoid potassium-rich foods entirely, discuss your dietary potassium intake with your doctor, especially if you have kidney disease.

Alcohol: Alcohol can lower blood pressure and may enhance the blood pressure-lowering effect of olmesartan, increasing the risk of dizziness or lightheadedness. Moderate alcohol consumption is generally acceptable.

Olmesartan dosing is straightforward ^[1].

Adults (hypertension): - Starting dose: 20 mg once daily ^[1] - Dose range: 20-40 mg once daily - Maximum dose: 40 mg once daily - If additional blood pressure reduction is needed after 2 weeks, dose may be increased to 40 mg ^[1]

Children 6-16 years: - 20 to <35 kg: Starting dose 10 mg once daily; maximum 20 mg/day ^[1] - ≥35 kg: Starting dose 20 mg once daily; maximum 40 mg/day

Volume-depleted patients: - Consider starting at a lower dose or correcting volume depletion before initiating ^[1]

Renal impairment: No dose adjustment needed for mild to moderate renal impairment. Use with caution in severe renal impairment (limited data) ^[1].

Hepatic impairment: No dose adjustment needed ^[1].

Administration: Take once daily at the same time each day, with or without food. Can be taken in the morning or evening.

Olmesartan is available as a generic medication ^{[1, 3]}.

Typical pricing (approximate 2025 prices): - Brand-name Benicar: $8-12 per tablet ($240-360/month) - Generic olmesartan: $0.20-1.00 per tablet ($6-30/month)

Savings strategies: - Generic substitution: Generic olmesartan has been available since 2016 ^[3]. Most prescriptions are filled with generic. - $4 generic programs: Many pharmacies include generic olmesartan in their discount generic programs. - Pharmacy discount programs: GoodRx and similar programs often show prices under $15/month. - Insurance: Most plans cover generic olmesartan with low copays.

Pregnancy (BLACK BOX WARNING): Olmesartan is contraindicated in pregnancy ^[1]. Drugs that act on the renin-angiotensin system can cause fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformities, and death when used during the second and third trimesters. Discontinue olmesartan as soon as pregnancy is detected. Women of childbearing potential should use effective contraception.

Breastfeeding: It is not known whether olmesartan is excreted in human breast milk ^[1]. Because of potential adverse effects on nursing infants, a decision should be made whether to discontinue nursing or the drug.

Generic olmesartan has been available since 2016 ^[3].

Brand name (Benicar): - Manufactured by Daiichi Sankyo - Tablets: 5 mg, 20 mg, 40 mg

Generic olmesartan medoxomil: - Multiple manufacturers produce FDA-approved generics - Available in all tablet strengths - Rated therapeutically equivalent by the FDA

Combination products: - Benicar HCT (olmesartan + hydrochlorothiazide): available generically - Azor (olmesartan + amlodipine): available generically - Tribenzor (olmesartan + amlodipine + HCTZ): available generically

Other ARBs: If olmesartan is not suitable (e.g., sprue-like enteropathy concern), alternatives include losartan, valsartan, irbesartan, candesartan, and telmisartan.